Oncology Biomarkers Market Worth US$9.5 billion by 2014 - New Report by MarketsandMarkets
(PRWEB) December 07, 2013 -- According to a new market research report, "Oncology Biomarker Market", published by MarketsandMarkets, The global oncology biomarker market is expected to grow from $4.1 billion in 2009 to $9.5 billion in 2014 at a CAGR of 18.1% from 2009 to 2014. The Global Oncology Biomarkers Market report analyzes the oncology biomarkers diagnostics and discovery market over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities for the oncology biomarkers market.
Browse more than 45 market data tables and in-depth TOC on "Oncology Biomarkers Market".
http://www.marketsandmarkets.com/Market-Reports/oncology-biomarkers-202.html
Early buyers will receive 10% customization on this report.
The global oncology biomarker market is expected to grow from $4.1 billion in 2009 to $9.5 billion in 2014 at a CAGR of 18.1% from 2009 to 2014. The key factors driving the growth of the overall oncology biomarkers market include the rising prevalence of cancer across the globe; and the early diagnosis and enhanced testing capabilities biomarkers facilitate. Further, U.S. government initiatives and increasing patient awareness are also enhancing market growth.
Market players are now focusing on new product and consolidations to enhance their commercial portfolios. The most common strategies adopted by market players include agreement and collaborations to stabilize management costs and to take advantage of the core competencies of the partner company.
Browse related reports
Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 - 2018
http://www.marketsandmarkets.com/Market-Reports/cancer-tumor-profiling-market-1250.html
Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 - 2018)
http://www.marketsandmarkets.com/Market-Reports/biomarkers-advanced-technologies-and-global-market-43.html
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including agriculture, advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog at http://mnmblog.org/market-research/healthcare/pharmaceuticals.
Connect with us on LinkedIn at http://www.linkedin.com/company/marketsandmarkets.
Rohan, MarketsandMarkets, http://www.marketsandmarkets.com/, +91 9881155004, [email protected]
Share this article